Copyright: ©Author(s) 2026.
World J Hepatol. Aug 27, 2026; 18(8): 124436
Published online Aug 27, 2026. doi: 10.4254/wjh.124436
Published online Aug 27, 2026. doi: 10.4254/wjh.124436
Table 3 Multivariable linear regression analysis of factors associated with ln-transformed small dense low-density lipoprotein levels
| Variable | B (95%CI) | Standardized β | P value |
| MetS | 0.76 (0.26 to 1.26) | 0.27 | 0.003 |
| Age | -0.004 (-0.03 to 0.02) | -0.03 | 0.750 |
| Female sex | -0.14 (-1.00 to 0.72) | -0.03 | 0.745 |
| BMI | 0.024 (-0.03 to 0.07) | 0.08 | 0.354 |
| Statin therapy | -0.45 (-1.04 to 0.13) | -0.13 | 0.133 |
| Fibrate therapy | -0.01 (-0.53 to 0.51) | -0.004 | 0.964 |
| Model statistics: R2 = 0.093 adjusted R2 = 0.054 F = 2.393 P = 0.031 | |||
- Citation: Koky T, Drazilova S, Janicko M, Harhovsky M, Hubkova B, Tothova I, Rabajdova M, Marekova M, Jarcuska P. Small dense low-density lipoprotein in primary biliary cholangitis: Independent association with metabolic syndrome. World J Hepatol 2026; 18(8): 124436
- URL: https://www.wjgnet.com/1948-5182/full/v18/i8/124436.htm
- DOI: https://dx.doi.org/10.4254/wjh.124436